BLACKLEDGER Selling Watch: VKTX, URG, USD/CAD
BLACKLEDGER's latest selling watch update tracks VKTX, URG, USD/CAD, AVGO, MVST, NZD/USD from the active public watchlist. This post is built from public-safe status data, in-house public signal labels, and outside public source context. It is designed to help readers understand what is happening around each asset without exposing private research methods.
Selling Watch Data
The dedicated feed category for this update is Selling. The latest public scan timestamp is 2026-09-15T08:00:36.373197+00:00.
- VKTX (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- URG (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- USD/CAD (forex): Bear public bias, Extended, public score 8.3/10, status: Paper trading research.
- AVGO (stock): Bear public bias, Extended, public score 8.0/10, status: Paper trading research.
- MVST (stock): Bear public bias, Extended, public score 8.0/10, status: Paper trading research.
- NZD/USD (forex): Bear public bias, Extended, public score 8.0/10, status: Paper trading research.
- RIVN (stock): Bear public bias, A-List, public score 7.5/10, status: Paper trading research.
- CCJ (stock): Bear public bias, A-List, public score 7.5/10, status: Paper trading research.
Educational Context: How To Use This Page
This page is not a trade instruction. It is an educational research brief. Readers can use it to understand company or project background, public market context, public status labels, and relevant outside-source headlines before doing their own due diligence.
VKTX Public Research Bio
Name: Viking Therapeutics, Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystr
- Latest public price/reference: $31.53
- Public market capitalization: $3.68B
- Recent public volume/reference: 1.84M
- One-month public movement: -3.31%
- Sector/category: Healthcare
Why VKTX Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Can Viking Therapeutics Beat Big Pharma With Monthly Weight-Loss Shots? Here’s The Risk CEO Says Could Derail It — Stocktwits
- Viking Therapeutics Advances VK2735 Obesity Drug Into Phase 3 After 15% Weight Loss — MarketBeat
- Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? — Zacks
- Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors — Zacks
URG Public Research Bio
Name: Ur-Energy Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
Ur-Energy Inc. engages in the acquisition, exploration, development, and operation of uranium mineral properties in the United States. It holds interests in 12 projects located in the United States. The company's flagship property is the Lost Creek project covering an area of approximately 1,800 unpatented mining claims and three Wyoming mineral leases covering an area of approximately 35,400 acres located in the Great Divide Basin, Wyoming. Ur-Energy Inc. was incorporated in 2004 and is headquartered in Littleton, Colorado.
- Latest public price/reference: $1.25
- Public market capitalization: $497.33M
- Recent public volume/reference: 9.17M
- One-month public movement: -0.79%
- Sector/category: Energy
Why URG Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Uranium Energy Stock Is Priced On Pounds It Has Not Sold Yet — Trefis
- From Yellowcake to Commercial Scale: Can Ur-Energy (URG) Live Up to Its Uranium Hype? — Insider Monkey
- Ur-Energy (URG) Q2 2026 Earnings Call Transcript — Motley Fool
- Ur-Energy Inc (URG) (Q2 2026) Earnings Call Highlights: Production Surges 47% as Shirley Basin ... — GuruFocus.com
USD/CAD Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: USD/CAD. Market class: forex. Public bias: Bear. Public tier: Extended.
Outside-source profile data was limited for this asset at publication time, so this section focuses on public BLACKLEDGER status data and verified public market context.
- Latest public price/reference: not available
- Public market capitalization: not available
- Recent public volume/reference: not available
- One-month public movement: not available
- Sector/category: not available
Why USD/CAD Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- No fresh public headlines were available from the automated outside-source pull. The asset r[redacted]ins covered through public status data.
AVGO Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Broadcom Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
Broadcom Inc. designs, develops, and supplies various semiconductor devices and infrastructure software solutions internationally. The company operates in two segments: Semiconductor Solutions and Infrastructure Software. The company offers networking connectivity, such as custom silicon solutions, ethernet switching & routing, ethernet NIC controllers, physical layer devices, and fiber optic components; wireless device connectivity, including RF semiconductor devices, connectivity solutions, custom touch controllers, and inductive charging ASICS; servers and storage system solutions, such as PCIE switches, SAS & raid products, fibre channel products, and HDD & SSD solutions; broadband solutions, includes set-top box, and broadband access; and industrial. The company also offers a private cloud software portfolio, including the VMware Cloud Foundation, Edge, vSphere foundation, telco cloud platform, private AI, live recovery, applicatio
- Latest public price/reference: $344.7
- Public market capitalization: $1645.57B
- Recent public volume/reference: 31.90M
- One-month public movement: -12.11%
- Sector/category: Technology
Why AVGO Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Tech pulls back on AI concerns, cybersecurity takes a step up — Yahoo Finance Video
- Chip Stocks Sink on AI Slowdown Calls, But Analysts Doubt a Crash Is Near — BeInCrypto
- AI Slowdown Debate Splits Tech CEOs: Nvidia, Broadcom Dismiss Any Threat While Elon Musk Calls For Peer Review System — Stocktwits
- 3 Stocks That Offer AI Exposure and Dividends — Zacks
MVST Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Microvast Holdings, Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
Microvast Holdings, Inc. engages in the design, development, and manufacturing of battery components and systems primarily for electric commercial vehicles and energy storage systems. The company offers a range of cell chemistries, such as lithium titanate oxide, lithium iron phosphate, electrolyte formulation, full concentration gradient cathode, polyaramid separator, and nickel manganese cobalt. It also designs, develops, and manufactures components of lithium-ion batteries, such as cathode, anode, electrolytes, and separator. The company's commercial vehicle markets cover buses, trains, mining trucks, marine and port vehicles, and automated guided and specialty vehicles, as well as light, medium, and heavy-duty trucks. It operates in China, India, rest of the Asia Pacific, Italy, France, rest of Europe, and the United States. Microvast Holdings, Inc. was founded in 2006 and is headquartered in Stafford, Texas.
- Latest public price/reference: $0.581
- Public market capitalization: $223.34M
- Recent public volume/reference: 7.47M
- One-month public movement: -29.23%
- Sector/category: Consumer Cyclical
Why MVST Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Microvast Holdings, Inc. Q2 2026 Earnings Call Summary — Moby
- Microvast Holdings Inc (MVST) (Q2 2026) Earnings Call Highlights: European Growth and ... — GuruFocus.com
- Microvast Q2 Earnings Call Highlights — MarketBeat
- Should You Buy Microvast Holdings (MVST) After a Sharp Decline? — Insider Monkey
NZD/USD Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: NZD/USD. Market class: forex. Public bias: Bear. Public tier: Extended.
Outside-source profile data was limited for this asset at publication time, so this section focuses on public BLACKLEDGER status data and verified public market context.
- Latest public price/reference: not available
- Public market capitalization: not available
- Recent public volume/reference: not available
- One-month public movement: not available
- Sector/category: not available
Why NZD/USD Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- No fresh public headlines were available from the automated outside-source pull. The asset r[redacted]ins covered through public status data.
What The Public Data Shows
The public feed highlights ticker status, market class, directional bias, score, tier, confidence, company or project profile, public market references, and outside-source headlines. These fields support a deeper view of BLACKLEDGER's public research feed while keeping private methods undisclosed.
Why This Category Matters
The Selling section gives readers a focused path through the market: buying watch content for constructive candidates, selling watch content for defensive movement, investing content for higher-quality public watch names, and market trend notes for broader context.
Research-Only Notice
BLACKLEDGER content is market research only. There is no live execution signal, no recommendation to buy or sell, and no financial advice. Readers should perform their own due diligence and consult licensed professionals before making financial decisions.
Research-only. No execution signal. Not financial advice.